Gematologiya i Transfuziologiya

(The median citation count of Gematologiya i Transfuziologiya is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
Thermolability of factor VIII in donor fresh frozen blood plasma6
Cytogenetic and molecular genetic diagnostics in oncohematological disorders: a position paper of the Organization of Molecular Geneticists in Oncology and Oncohematology6
Minimal residual disease and b-cell subpopulation monitoring in acute b-lymphoblastic leukaemia patients treated on rall-2016 protocol4
Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma4
Detection of measurable residual disease in adults with acute leukaemia4
Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question4
Risk-adapted combined therapy with arsenic trioxide and all-trans-retinoic acid for de novo acute promyelocytic leuкaemia3
Implementation of allogeneic hematopoietic stem cell transplantation from unrelated donors from Russian and foreign registries3
National clinical recommendations for the diagnosis and treatment of mastocytosis3
Clinical guidelines for the management of patients with paroxysmal nocturnal hemoglobinuria3
Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia3
Observation in a treatment-free remission in chronic myeloid leukemia patients with a stable deep molecular response in the Russian portion of the international multicenter population based study EUTO3
Comparison of the treatment results in adult patients with acute Ph-negative lymphoblastic leukemia on protocols of the Russian multicenter studies ALL-2009 and ALL-20163
A prospective study of the monitoring of patients with chronic myeloid leukemia upon withdrawal of tyrosine kinase inhibitor therapy3
Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency2
Next generation sequencing HLA-typing of recipients and donors of allogeneic haematopoietic stem cells2
Next-generation sequencing-based molecular genetic profiling in adults with acute myeloid leukaemia2
Myeloidderived peripheral blood suppressor cells at haematopoietic stem cell mobilisation in multiple myeloma patients2
Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma2
Formation of a cohort of anticovid plasma donors with high-titer antibodies neutralizing SARS-CoV-22
Treatment tactics for a patient with acquired hemophilia: continuous infusion of recombinant activated coagulation factor VII and the inhibitor eradication2
Coexistence of multiple myeloma and chronic myeloleukosis in one patient2
The role of D-dimer in stroke risk stratification in patients with atrial fibrillation2
Endothelial-platelet interaction in sepsis2
Immunoglobulin genes and stereotyped antigenic receptors in chronic lymphocytic leukemia and other lymphoproliferative diseases2
Methodological aspects of the detection of minimal residual disease in patients with acute leukemia2
Management of patients with hemophilia A on emicizumab prophylactic treatment: Recommendation from Russian Experts1
Impact of natural killer cell’s functional reconstruction on the results of allogeneic hematopoietic stem cell transplantation1
A comprehensive measures ensuring the safety of blood component transfusions1
Role of the intensive care in allogeneic hematopoietic stem cell transplantation1
Identifi cation of ABO, RH and KEL blood group antigens with serology and genotyping methods1
First experience of allogeneic haematopoietic stem cell transplantation in patients with mantle cell lymphoma with a mutation in the <i>TP53</i> gene1
Kaposi’s sarcoma in HIV-negative patient with primary myelofi brosis1
Experience of haematological observatory ward during COVID-10 pandemic1
Dynamic laboratory control of iron deficiency correction in neurosurgical patients1
Successful treatment of relapses of primary mediastinal large B-cell lymphoma with central nervous system involvement1
Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy1
Physiological and pathological role of factor XII1
Oligoclonality and subpopulation structure of bone marrow T-cells in patients with aplastic anaemia1
COVID-19 in patients with congenital bleeding disorders in Russia1
Supplement intravenous iron therapy in cardiac surgery1
Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients1
Advantages and disadvantages of femoral port systems in hematоlogical patients with superior vena cava syndrome1
Hemophilia in the city of Novosibirsk and Novosibirsk region: Clinical phenotype, comorbidity1
Infectious complications and their contributing risk factors after allogeneic hematopoietic stem cell transplantation1
Cytokines in the mechanisms of regulation of monocytopoiesis in ischemic heart disease1
Conformational disorders of RBC membranes during long-term storage1
Regional hematology service registration system for the Russian Federation1
Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines1
Characteristics and trends in the work of the Blood Service of the Russian Federation in 2016–20201
Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura — diagnostic difficulties and errors1
Clinical guidelines for cryosupernatant transfusions1
Blood groups and acute respiratory viral infection COVID-191
Anemia in primary hyperparathyroidism1
Whole-body magnetic resonance imaging for diagnosis and treatment monitoring in multiple myeloma1
Management of immune thrombocytopenia during COVID-19 pandemic1
Minor histocompatibility antigens as targets for T-cell immunotherapy1
Significance of TPMT and NUDT15 variants in 6-mercaptopurine metabolism in acute lymphoblastic leukaemia/lymphoma patients1
Chimeric antigen receptor T-cell therapy in adult patients with B-cell lymphoproliferative diseases1
A long-term follow-up of observation in treatment-free remission in patients with chronic myeloid leukemia1
Optimal blood management as priority route in cardiac surgery1
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia1
Evaluation of the effi ciency of the activity of the register of potential donors of hematopoietic stem cells1
Molecular and genetic verification of von Willebrand disease type 2N1
The frequency of detection of anti-HBc in blood donors from four regions of Russia0
Clinical observation of chronic myeloid leukemia with variant translocation and supplementary rearrangement t(1;8)(q23;q24.3)0
The introduction of Laboratory testing for anti-HBcore in blood donors0
Acute tumor lysis syndrome — an urgent multidisciplinary problem in pediatric hematology0
Transformation of indolent lymphomas into diffuse large B-cell lymphoma0
Safety of plasma-derived blood products transfusions harvested from anti-SARS-CoV-2 positive and negative donors0
Global tests in patients with Ph-negative myeloproliferative neoplasms0
Surgical treatment of hemophilic arthropathy of subtalar joint in a patient with severe hemophilia B0
Storage of pathogen-reduced platelets0
Transfusiology as a medical specialty in modern Russia (25th anniversary of the introduction of the specialty «Transfusiology» into the nomenclature of medical and pharmacological specialties)0
Blood groups and oncological diseases0
Intensive care of life-threatening complications in allogeneic hematopoietic stem cell recipients0
Haemovigilance in the United Kingdom0
Cytological and cytochemical diagnosis of sideroblastic anemia0
Expression of PD-1 and TIM-3 inhibitory checkpoint molecules by T-lymphocytes in early post-transplant period in multiple myeloma patients0
Biofi lm production among Candida spp. causing invasive candidiasis in patients with hematological malignancies and without hematological malignancies0
Comparison of quantitative and qualita- tive characteristics of the system von Willebrand factor — metalloprotease ADAMTS13 in patients with acute myocardial in farction and is chemic stroke0
Qualitative platelet alterations in May — Hegglin anomaly0
Comparative study of the effect of tranexamic acid and exogenous fibrin monomer on fibrin formation in the injury area during stimulation of fibrinolysis by streptokinase0
Effi cacy of splenectomy in primary immune thrombocytopenia0
Acute lymphoblastic leukemias in twins0
The experience with Brentuximab vedotin in the treatment of lymphomatoid papulosis in a pediatric patient0
Analysis of mutations in EPOR, VHL, EPAS1 and EGLN1 genes associated with the familial erythrocytosis ECYT1-4 among JAK2- and CALR-negative patients with the erythrocytosis of unclear etiology0
MEK-kinase Inhibitor as a treatment option for hairy cell leukemia0
Effect of increasing the number of repeated measurements on the accuracy of determining factor VIII activity and fibrinogen concentrations in blood plasma0
Changes in the activity of metalloprotease ADAMTS13 antigen von Willebrand factor in patients with acute coronary syndrome0
The characterization and frequency of diagnosis of EBV-positive variants with a lymphoid predominance in the structure of Hodgkin lymphoma0
The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management0
Incidence and mortality rates of tumors of the hematopoietic and lymphoid tissues in a cohort of workers chronically exposed to ionizing radiation0
High-dose chemotherapy with transplantation of autologous hematopoietic stem cells in the first line of follicular lymphoma therapy0
Comparative study of the quality of screening of donated blood for the presence of molecular markers of viral infections0
The role of interleukin-3 and its receptor in acute leukemia pathogenesis0
Measures of social support for blood donors during the formation of the donor movement in the USSR0
COVID-19 infection in patients undergoing allogeneic hematopoietic stem cell transplantation0
Laboratory features of hemoglobinopathies0
Comparison of quantitative and qualitative characteristics of the system “P-selectin — platelets — von Willebrand factor — metalloprotease ADAMTS13” in patients with sepsis, idiopathic thrombocytopeni0
Extracorporeal photopheresis in the treatment of chronic graft-versus-host-disease0
The Role of epigenetic modifications of DNA and histones in the treatment of oncohematological diseases0
Treatment results of children and adolescents with relapsed AML who were initially treated according to the AML-MM-2006 protocol0
Effect of low concentration of melatonin on the quality of stored red blood cells <em>in vitro</em>0
Formation of collective immunity against a new coronavirus infection COVID-19 in blood donors0
Staffing of the hematology service of the Russian Federation0
Recommendations for the diagnosis and treatment of bone marrow form of acute radiation syndrome0
Using a thrombodynamics test for diagnostics of hypercoagulation and prediction of thromboembolic complications in patients with malignant tumors0
The effect of cryopreservation on the parameters of mononuclear apoptosis during extracorporeal photopheresis0
Features of clinical and laboratory diagnosis of rare coagulopathy – acquired hemophilia0
The effect of phototherapy on the dynamics of cytokine mRNA expression in the affected skin of patients with mycosis fungoides0
Clonal hematopoiesis and its role in the development of hematological diseases0
Allogeneic haematopoietic stem cell transplantation with reduced-intensity conditioning in chronic myeloid leukaemia0
The use of a growth factor inhibitor in the treatment of recurrent bleeding in von Willebrand disease0
Infections of the soft tissues of the perianal region in patients with tumor diseases of the blood system0
ALCL Protocol of the DOIG Research Institute 2003: results of treatment of anaplastic large cell lymphoma in children in a comparative multicenter clinical trial0
HLA allele repertoire in Russian chronic lymphocytic leukemia patients with an unfavorable prognosis0
Large B-cell lymphoma with IRF4 rearrangement0
Obinutuzumab in combination with chlorambucil in first line treatment of elderly patients with chronic lymphocytic leukemia0
Platelet Delta granules storage pool deficiency in female patient with severe hemorrhagic syndrome0
The use of pegaspargase in adult Ph-negative acute lymphoblastic leukemia patients in the treatment according to the all-2016 protocol0
Thromboelastometry for predicting hemostasis disorders after cardiopulmonary bypass during cardiac surgery0
The state of hemostasis system in patients after mild coronavirus infection0
The role of estimation of plasma von Willebrand factor concentration in stroke risk stratification in patients with atrial fibrillation0
How I treat peripheral T-cell lymphomas0
Successful diagnosis and treatment of fusariosis in patient with acute leukemia0
Guidelines for the diagnosis and management of idiopathic thrombocytopenic purpura0
Essential thrombocythemia in children and adolescents — analysis of 31 cases0
Study of the Janus kinase 2 (JAK2) gene haplotype 46/1 association with driver mutations of chronic Ph-negative myeloproliferative neoplasms0
Intravascular large B-cell lymphoma with isolated bone marrow involvement0
Thrombosis in patients with hereditary fibrinogen deficiency0
Use of eltrombopag in treatment programs for patients with aplastic anemia0
Clinical impact of plasma haemostasis disorders and their correction in chronic glomerulonephritis with nephrotic syndrome0
Frequency of coexistence and kinetics of the BCR-ABL1 transcript level and allele burden of JAK2V617F and CALR Type 1, 2 gene mutations in patients with chronic myeloid leukemia0
The incidence of impaired binding capacity of von Willebrand factor to collagen types I and III in patients with type 1 von Willebrand disease0
Combination of ibrutinib and venetoclax followed by Chimeric Antigen Receptor T-cell therapy in the first line of treatment in an elderly patient with mantle cell lymphoma with hyperleukocytosis and mu0
The incidence of Ph-negative chronic myeloproliferative neoplasms in Belarus0
Analysis of the effectiveness of the SIRS, qSOFA and MEWS scale for the sepsis identification in oncohematological patients. Gematologiya i transfuziologiya0
A comprehensive study of rare Rhesus phenotype case0
Evaluation of the relative allelic load of mutations of resistance to ibrutinib in the <i>BTK</i> gene by allele-specific PCR in patients with progression of CLL0
Application of conditioned medium from mesenchymal stromal cells in the protocol for <em>ex vivo</em> production of megakaryocytes and platelets0
Comparative characteristics of bone marrow cell composition, stroma, and trabecular bone in allogenic hematopoietic stem cell transplantation in patients with primary myelofibrosis0
Long-term results of therapy for chronic myeloid leukemia: a 20-year analysis of the use of tyrosine kinase inhibitors in Russia0
Acute megakaryocytic leukemia with acquired trisomy 21 and structural chromosomal rearrangements in a young child0
Total knee arthroplasty in a female with a severe form of hemophilia A0
Early and late relapses of multiple myeloma after autologous haematopoietic stem cell transplantation0
Congenital thrombotic thrombocytopenic purpura in children0
Comparison of morbidity and results of chronic myeloid leukemia treatment in Novosibirsk and the Novosibirsk region0
Collection, transportation and storage of blood during the Great Patriotic War0
Low molecular weight heparin prophylaxis for placenta-mediated complications in women with F2G20210A mutation0